The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity
Author(s):
Mukhopadhyay, P.; Baggelaar, M.; Erdelyi, K.; Cao, Z.; Cinar, R.; Fezza, F.; Ignatowska-Jankowska, B.; Wilkerson, J.; Gils, N. van; Hansen, T. (0000-0002-6291-1569); Ruben, M.; Soethoudt, M.; Heitman, L.; Kunos, G.; Maccarrone, M.; Lichtman, A.; Pacher, P.; Stelt, M. van der (0000-0002-1029-5717)
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-02-28
Language
English
Is part of
British Journal of Pharmacology (2016), Vol. 173, no. 3, p. 446–458
